[Clinical application of an antiprogesterone preparation, RU 486].
Taketani
Y
Y
Ishihara
T
T
Go
M
M
Mizuno
M
M
D000019:Abortifacient Agents; D000028:Abortion, Induced; D001208:Asia; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D019049:Developed Countries; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005202:Asia, Eastern; D006727:Hormone Antagonists; D006728:Hormones; D007564:Japan; D015735:Mifepristone; D010827:Physiology
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Asia; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Postcoital; Critique; Developed Countries; Eastern Asia; Endocrine System; Family Planning; Fertility Control, Postconception; Hormone Antagonists; Hormones; Japan; Physiology; Ru-486--administraction and dosage; Ru-486--beneficial effects; Ru-486--pharmacodynamics